Clinical Decision Support: The Regulatory and Practical Implications of a Rapidly Developing Power Tool

While clinical decision support tools, especially with the advent of artificial intelligence, have the potential to greatly improve patient care, there are concerns related to patient health and safety and fraud and abuse. Anthony Burba, Partner, Barnes & Thornburg LLP, and Gail Javitt, Director, Hyman Phelps & McNamara PC, discuss the promise and perils of these tools, navigating the Food and Drug Administration’s regulatory efforts, issues related to data storage and validation, and advising providers who are implementing these tools. Anthony and Gail spoke about this topic at AHLA’s 2023 Annual Meeting in San Francisco, CA.Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.